Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07163065

Evaluation of Systemic Inflammatory Index and Biomarkers in Relation to Inferior Alveolar Nerve Block Success and Postoperative Pain

Effect of Systemic Inflammatory Index and Other Biomarkers on Inferior Alveolar Nerve Block Success and Postoperative Pain

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
KEZBAN MELTEM ÇOLAK · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the relationship between systemic inflammatory markers and the effectiveness of inferior alveolar nerve block anesthesia in patients undergoing dental treatment. The primary focus is on the Systemic Inflammatory Index (SII) and other inflammatory biomarkers, and how they may influence both the success of anesthesia and the intensity of postoperative pain. By analyzing blood samples and clinical outcomes, the study will provide new insights into the role of systemic inflammation in anesthesia effectiveness and postoperative pain control. The findings may help clinicians predict anesthetic success and improve pain management strategies in dental practice.

Detailed description

Pulpitis is among the most common causes of orofacial pain. Irreversible pulpitis is characterized by a painful pulpal response to thermal stimuli that does not subside immediately after the removal of the stimulus. Pain is an unpleasant experience associated with actual or potential tissue damage. It is a subjective concept, and the pain threshold varies among individuals. Cold and heat tests are widely used in clinical practice for the diagnosis of symptomatic irreversible pulpitis. Irreversible pulpitis mainly arises due to infection caused by dental caries or the loss of restoration seal and microleakage. Dental trauma, pulpal exposure, and cracks can also lead to severe pulpitis. Pain associated with irreversible pulpitis accounts for more than 45% of emergency dental visits. A detailed history of pain is essential, and it is often described as severe, dull, and throbbing; this pain may intensify with thermal or postural changes and can result in sleep disturbance. It tends to persist for prolonged periods (minutes to hours) and is generally unresponsive to analgesics. Patients also frequently report spontaneous and unprovoked sharp pains. Achieving successful pulpal anesthesia during endodontic treatment of teeth with symptomatic irreversible pulpitis is critical for patient pain and stress management; however, this remains particularly challenging in mandibular teeth due to the inability of the inferior alveolar nerve block (IANB) to consistently provide profound anesthesia. Increased acidity in the inflamed pulp reduces the amount of basic anesthetic penetrating the nerve membrane, thereby delaying or preventing pulpal anesthesia. Lip numbness, which typically occurs after anesthesia (i.e., loss of tactile sensation due to A-beta fiber blockade), is commonly regarded as an indicator that pulpal pain fibers (C and A-delta fibers) are also anesthetized and that the patient is ready for treatment. However, while tactile sensation is mediated by A-beta fibers, pain is transmitted via C and A-delta fibers. Local anesthetics block thick myelinated A-beta fibers and thin myelinated A-delta fibers at much lower concentrations than unmyelinated C fibers. Local anesthetics thus preferentially block myelinated fibers. Therefore, in healthy patients, the presence of lip numbness may be misleading for assessing pulpal anesthesia success. In patients with irreversible pulpitis, this method of assessment is even more unreliable. \*\*Several theories have been proposed to explain anesthetic failure. However, no studies have investigated the relationship between systemic inflammation and anesthetic success. The systemic immune-inflammation index (SII) is a novel biomarker for inflammation and is calculated as (neutrophil count × platelet count) / lymphocyte count. In our study, SII and other inflammatory markers will be evaluated. These additional inflammatory indices are as follows: Aggregate index of systemic inflammation (AISI) = neutrophil count × monocyte count × platelet count / lymphocyte count Platelet-to-lymphocyte ratio (PLR) = platelet count / lymphocyte count Systemic inflammatory index (SII) = neutrophil count / PLR Neutrophil-to-lymphocyte ratio (NLR) = neutrophil count / lymphocyte count.\*\* Moreover, although NLR has been used as an indicator of the inflammatory response in numerous diseases, there are insufficient data regarding its effects on postoperative pain, which is closely associated with acute inflammation. The aim of this study is to investigate the effects of systemic inflammatory markers, particularly SII and NLR, on the success of inferior alveolar nerve block anesthesia and postoperative pain.

Conditions

Interventions

TypeNameDescription
PROCEDUREInferior Alveolar Nerve Block AnesthesiaStandard inferior alveolar nerve block anesthesia performed with lidocaine and epinephrine for mandibular dental treatment. Success rate and postoperative pain outcomes will be recorded

Timeline

Start date
2024-09-27
Primary completion
2024-11-01
Completion
2025-10-15
First posted
2025-09-09
Last updated
2025-09-09

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07163065. Inclusion in this directory is not an endorsement.